PROCAREPLUS PHARMA SPÓŁKA AKCYJNA

TAX ID6793195348

KRS0000824923

Share capital154,380.40 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW

Show on map

Website

www.pcppharma.pl

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

PROCAREPLUS PHARMA SPÓŁKA AKCYJNA

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW

Show on map

NIP

6793195348

REGON

385372588

KRS

0000824923

Legal form

joint stock company

Register Address

UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348 KRAKÓW

Date of registration in KRS

2020-01-24

Date of commencement of economic activity

2020-01-24

Act signature

KR.XI NS-REJ.KRS/17407/25/732

Website

WWW.PCPPHARMA.PL

Pkd codes

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

21.10.Z - Manufacture of basic pharmaceutical products

32.50.Z - Production of medical devices, instruments, and products, including dental products

32.99.Z - Production of other products not classified elsewhere

46.18.Z - Activity of agents involved in wholesale trade of other specified goods

46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods

46.46.Z - Wholesale trade of pharmaceutical and medical products

47.73.Z - Retail sale of pharmaceutical products

47.74.Z - Retail sale of medical and orthopedic products

72.11.Z - Scientific research and development activities

Payer VAT status

exempted

Company authorities

representation authorityMANAGEMENT

supervisory authorityboard of directors

representation type

W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO SPÓŁKĘ REPREZENTUJE JEDYNY CZŁONEK ZARZĄDU SAMODZIELNIE. W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO SPÓŁKĘ REPREZENTUJE PREZES ZARZĄDU LUB DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2020	2021
	M PLN	M PLN	%
Gross profit (loss)	-0,3	-1	-247,2
EBITDA	-0,3	-1	-244,8
Short time liabilities	0,2	0,2	-13
Equity capital	0,4	0,8	92,8
Operating profit (EBIT)	-0,3	-1	-244,8
Assets	0,6	1,1	63,8
Net profit (loss)	-0,3	-0,9	-247,1
Cash	0,2	0,2	29,6
Net income from sale	0	0,3	578,1
Liabilities and provisions for liabilities	0,2	0,3	17,6
Working assets	0,4	0,4	9,7
Depreciation	0	0	0
	%	%	p.p.
Profitability of capital	-66,8	-120,3	-53,5
Equity capital to total assets	61,4	72,3	10,9
Gross profit margin	-719,4	-368,3	351,1
EBITDA Margin	-725,7	-369	356,7
	Days	Days	Days
Short term commitment turnover cycle	2155	277	-1878

Current financial liquidity indicator	1.5484055280685425	1.9203954935073853	0,4
Net dept to EBITDA	-0.1020432561635971	0.14928516745567322	0,2